Key result
Reambirin and Remaxol linked to fewer complications and better recovery in urgent abdominal surgery.
Why the study?
Does complex therapy including Reambirin and Remaxol reduce the incidence of complications in patients undergoing urgent abdominal surgery?
Does complex therapy including Reambirin and Remaxol reduce the incidence of complications in patients undergoing urgent abdominal surgery?
Complex therapy with Reambirin and Remaxol may improve early postoperative outcomes in urgent abdominal surgery, potentially making open surgery outcomes comparable to laparoscopic ones.
May warrant Reambirin-Remaxol therapy in urgent abdominal surgery; extends evidence equating open to laparoscopic outcomes.
Effectiveness of complex therapy, including Reambirin and Remaxol, is based on its ability to affect key pathogenetic oxidative-toxic components that directly affects early postoperative period and incidence of complications. Positive effects appear early after surgery. The undoubted result of studies in urgent abdominal pathology is establishment of possible approximating the results of open traumatic surgical interventions to laparoscopic ones.
No takes yet. Share an insight, caveat, or question.
Muratova et al. (2026) studied this question. Complex therapy with Reambirin and Remaxol improves the early postoperative period and reduces complications in urgent abdominal surgery, approximating open surgery outcomes to laparoscopic ones.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: